Elicio Therapeutics, Inc. (ELTX)
2.41
-0.09
(-3.60%)
USD |
NASDAQ |
Sep 04, 16:00
2.425
+0.02
(+0.62%)
After-Hours: 20:00
Elicio Therapeutics Net Income (Annual) : -39.57M for Dec. 31, 2025
Net Income (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Income (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | -39.57M |
| December 31, 2024 | -51.90M |
| December 31, 2023 | -35.20M |
| December 31, 2022 | -28.21M |
| December 31, 2021 | -54.57M |
| Date | Value |
|---|---|
| December 31, 2020 | -80.11M |
| December 31, 2019 | -40.66M |
| December 31, 2018 | -20.02M |
| December 31, 2013 | 1.280M |
| December 31, 2012 | 0.9921M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Annual) Benchmarks
| Precigen, Inc. | -250.64M |
| Agenus, Inc. | -3.083M |
| Amgen, Inc. | 7.711B |
| Anika Therapeutics, Inc. | -9.979M |
| BioCryst Pharmaceuticals, Inc. | 263.86M |